April 16, 2015

MolecularMD Announces Presentations at Upcoming American Association for Cancer Research Annual Meeting

PORTLAND, OR and CAMBRIDGE, MA – April 16, 2015 – MolecularMD, Corp., a molecular diagnostics company that develops custom companion diagnostic products and supports clinical trial services for targeted cancer therapies, today announced that its Next Generation Sequencing (NGS) capability will be highlighted in two presentations at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2015 taking place April 18 -22 in Philadelphia, PA. MolecularMD scientists will present two posters describing the validation of Oncomine® Cancer Research Panel for comprehensive analysis of FFPE tumor samples, and the application of Ion AmpliSeq™ v2 Cancer Panel gene panel for Liquid Biopsy.

AACR Presentation Details: Title: Oncomine® Cancer Panel: simultaneous detection of clinically relevant hotspot mutations, CNVs and gene fusions in solid tumors Session Title: Genomics in the Clinic 1 Date & Time: Tuesday, April 21, 2015; 1:00 PM – 5:00 PM Section 23, Poster board number 18 Abstract Number: 4261

Title: Liquid biopsy using the Ion Ampliseq v2 Cancer PanelSession Title: New Technologies to Identify Genetic Alterations Date & Time: Wednesday, April 22, 2015; 8:00 AM – 12:00 PM Section 7, Poster board number 21 Abstract Number: 4925